- Home
- KURA vs BLMN Comparison
KURA vs BLMN Comparison
Compare KURA & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- BLMN
- Stock Information
- Founded
- KURA 2014
- BLMN 1988
- Country
- KURA United States
- BLMN United States
- Employees
- KURA N/A
- BLMN N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- BLMN Restaurants
- Sector
- KURA Health Care
- BLMN Consumer Discretionary
- Exchange
- KURA Nasdaq
- BLMN Nasdaq
- Market Cap
- KURA 713.5M
- BLMN 625.3M
- IPO Year
- KURA N/A
- BLMN 2012
- Fundamental
- Price
- KURA $10.14
- BLMN $7.55
- Analyst Decision
- KURA Buy
- BLMN Hold
- Analyst Count
- KURA 14
- BLMN 9
- Target Price
- KURA $24.45
- BLMN $9.25
- AVG Volume (30 Days)
- KURA 1.8M
- BLMN 2.1M
- Earning Date
- KURA 11-06-2025
- BLMN 11-07-2025
- Dividend Yield
- KURA N/A
- BLMN 7.98%
- EPS Growth
- KURA N/A
- BLMN N/A
- EPS
- KURA N/A
- BLMN N/A
- Revenue
- KURA $83,279,000.00
- BLMN $3,933,993,000.00
- Revenue This Year
- KURA $68.63
- BLMN $1.43
- Revenue Next Year
- KURA $141.59
- BLMN $1.47
- P/E Ratio
- KURA N/A
- BLMN N/A
- Revenue Growth
- KURA N/A
- BLMN 2.47
- 52 Week Low
- KURA $5.41
- BLMN $6.09
- 52 Week High
- KURA $19.73
- BLMN $17.57
- Technical
- Relative Strength Index (RSI)
- KURA 69.23
- BLMN 57.74
- Support Level
- KURA $9.48
- BLMN $7.18
- Resistance Level
- KURA $9.96
- BLMN $7.56
- Average True Range (ATR)
- KURA 0.41
- BLMN 0.28
- MACD
- KURA 0.06
- BLMN 0.10
- Stochastic Oscillator
- KURA 81.78
- BLMN 95.72
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.